First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Hope S. Rugo, MD, FASCO, discusses how the combination of elacestrant and abemaciclib compares with other treatment options for patients with advanced breast cancer, whether estrogen receptor-positive ...

Young, an internal medicine physician and a functional integrative medical specialist at the Center ... When it becomes activated, it signals the release of hormones, including adrenaline and cortisol ...